A case study of polypharmacy management in nine European countries

A case study of polypharmacy management in nine European countries

Single disease state led evidence-based guidelines do not provide sufficient coverage of issues of multimorbidities, with the cumulative impact of recommendations often resulting in overwhelming medicines burden. Inappropriate polypharmacy increases the likelihood of adverse drug events, drug interactions and non-adherence.

SIMPATHY project: stimulating innovation management of polypharmacy and adherence in the elderly
Funding Body
European Commission
Award Value
€1,015,473
Start Date
1 June 2015
End Date
31 May 2017
Duration
2 years

Cookie Consent